PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million)Business Wire • 11/02/20
PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample PoolingBusiness Wire • 10/29/20
PerkinElmer, Inc. (PKI) CEO Prahlad Singh on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/29/20
PerkinElmer Launches Industry First No-Wash Immunoassay For Phospho Ubiquitin Ser65 to Help Drive Neuroscience Disease and Therapeutics Research ForwardBusiness Wire • 10/26/20
PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19Business Wire • 10/26/20
PerkinElmer Immunoassay Helps NIH NCATS Team Identify Therapeutic Compounds Capable of Disrupting the SARS-CoV-2 Spike Protein/ACE2 InteractionBusiness Wire • 10/20/20
CORRECTING and REPLACING PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020Business Wire • 10/12/20
PerkinElmer Updates Third Quarter Outlook; To Hold Earnings Call on Wednesday, October 28, 2020Business Wire • 10/12/20
Newport, Wales Laboratory Goes Live as First Lighthouse Lab featuring PerkinElmer’s COVID-19 SolutionsBusiness Wire • 10/08/20
PerkinElmer Launches Industry First, Fully Automated Workflow for Cannabis & Hemp Pesticide Residue TestingBusiness Wire • 10/07/20
The FDA Just Ranked Coronavirus Tests by Sensitivity. Here's What That MeansThe Motley Fool • 10/03/20
PerkinElmer Signals Notebook and PerkinElmer Signals Medical Review Cloud-Based Software Gain SOC 2 Attestation for Biopharmaceutical Research and Clinical Trial DataBusiness Wire • 09/30/20